Resources and Products
Explore topics by clicking on one of the bubbles below.
- Bloodborne Pathogens
- Candida auris (C.auris)
- Carbapenem-Resistant Enterobacteriaceae (CRE)
- Clostridioides difficile (C.diff)
- Data Management
- Dialysis Settings
- Drug Diversion
- Epidemic Keratoconjunctivitis (EKC)
- Medical Products
- Nontuberculous Mycobacteria (NTM)
- Patient Notification
- Spotlight Series
Carbapenem-Resistant Enterobacteriaceae (CRE)
Enterobacteriaceae are a large family of different types of bacteria that commonly cause infections in healthcare settings. Examples include Escherichia coli (E. coli) and Klebsiella pneumoniae. Carbapenem-resistant Enterobacteriaceae (CRE) are a type of Enterobacteriaceae that are resistant to a group of antibiotics called carbapenems.
- CORHA’s Proposed Investigation/Reporting Thresholds and Outbreak Definition for Carbapenem-Resistant Enterobacteriaceae (CRE), which are intended to expedite recognition, reporting and investigation
- CDC’s Containment Strategy Guidelines, which outline guidance for a public health response to contain novel or targeted multidrug-resistant organisms (MDROs) including recommended approaches for three different tiers of organisms and resistance mechanisms
- CSTE’s Position Statement on Public Health Reporting and National Notification of Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE)
Health Departments conducting these investigations are encouraged to consult with CDC by contacting the healthcare outbreak duty officer at email@example.com.
CORHA Principles and Practices for Outbreak Response
CORHA Proposed Investigation/Reporting Thresholds and Outbreak Definition for Carbapenem-Resistant Enterobacteriaceae (CRE)